Elevance Health Inc (ELV)
Working capital turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 176,810,000 | 171,340,000 | 156,595,000 | 138,639,000 | 121,867,000 |
| Total current assets | US$ in thousands | 52,560,000 | 54,005,000 | 49,383,000 | 44,587,000 | 40,132,000 |
| Total current liabilities | US$ in thousands | 26,195,000 | 26,297,000 | 24,080,000 | 21,515,000 | 18,811,000 |
| Working capital turnover | 6.71 | 6.18 | 6.19 | 6.01 | 5.72 |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $176,810,000K ÷ ($52,560,000K – $26,195,000K)
= 6.71
Elevance Health Inc's working capital turnover has shown a positive trend over the years, indicating efficiency in utilizing its working capital to generate revenue. The ratio has increased steadily from 5.72 in 2020 to 6.71 in 2024, demonstrating an improvement in managing its operating cycle and assets. This suggests that the company is effectively converting its working capital into sales, which is a favorable sign of operational efficiency. Overall, the consistent rise in the working capital turnover reflects Elevance Health Inc's ability to efficiently utilize its resources to drive revenue growth.
Peer comparison
Dec 31, 2024